ReviewClinical Medicine Insights. Oncology2026

Advances in Immunotherapy for Head and Neck Squamous Cell Carcinoma: Focus on PD-1/PD-L1 Blockade and Beyond.

Fei Le et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.